Navidea Biopharmaceuticals, Inc. ( NAVB ) was a big mover last session with its shares rising over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 34% in the past one-month time frame.
This biopharmaceutical company has seen 1 positive estimate revision in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday's rally can turn into more strength down the road.
Navidea currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Investors interested in the medical industry may consider other well-placed stocks like RTI Surgical Inc. ( RTIX ), Alphatec Holdings, Inc. ( ATEC ) and Edwards Lifesciences Corp. ( EW ). While RTIX and ATEC sport a Zacks Rank #1 (Strong Buy), EW carries the same Zacks Rank as Navidea.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportNAVIDEA BIOPHAR (NAVB): Free Stock Analysis ReportRTI SURGICAL (RTIX): Free Stock Analysis ReportALPHATEC HLDGS (ATEC): Free Stock Analysis ReportEDWARDS LIFESCI (EW): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research